DEF 14A

Company

ARROWHEAD PHARMACEUTICALS, INC.

Filed

January 27, 2026

Period of Report

January 26, 2026

Accession Number

0000879407-26-000019

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →